Scientists test new wearable injector for common drug
NCT ID NCT07007091
Summary
This study tested a new wearable injection device for the drug risankizumab, which is used to treat conditions like psoriasis. Researchers compared how the body absorbs the drug when given by this new device versus a standard prefilled syringe. The study involved 260 healthy volunteers to check safety and how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 276043
Grayslake, Illinois, 60030, United States
-
Cpmi /Id# 276490
Miami, Florida, 33172, United States
-
PPD Phase I Clinic /ID# 276525
Austin, Texas, 78744, United States
-
Ppd - Las Vegas Research Unit /ID# 276565
Las Vegas, Nevada, 89113, United States
Conditions
Explore the condition pages connected to this study.